bone marrow transplantation
Stonefish Venom Research Could Combat Transplant Rejection
Understanding the crystal structure of stonefish toxin could help scientists design drugs that prevent transplant rejection driven by the perforin immune response.
Generon’s Recombinant IL-22 Receives US FDA Clearance For Phase IIa Trials
Following a successful Phase I study, Generon is moving its recombinant antibody F-652 to Phase IIa trials in collaboration with the Memorial Sloan-Kettering Cancer Center.
Making Bone Marrow Transplants Safer
A drug already approved for rheumatoid arthritis could also help prevent graft-versus-host disease in bone marrow transplant recipients.
